» Articles » PMID: 32042294

Substance P As a Potential Biomarker of Pain Assessment in Dogs

Overview
Journal Iran J Vet Res
Date 2020 Feb 12
PMID 32042294
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Substance P (SP) is a neuropeptide that functions as a neuromodulator. It is released mainly in the brain stem and in nerve endings.

Aims: The present study aimed to provide fundamental data that may be applied to the assessment of pain in dogs by evaluating their serum SP concentrations.

Methods: Two groups of dogs were designated as pain groups that included 10 dogs with medial patella luxation (MPL) and 10 dogs with fractures, respectively, and 20 healthy dogs were enrolled as the control group.

Results: The SP concentrations in the serum of the pain groups reached 485.5 ± 250.1 pg/ml that was significantly higher than those of the control group, which reached 116.4 ± 38.5 pg/ml. In particular, serum SP concentrations in dogs with fractures (663.3 ± 225.3 pg/ml) were significantly higher compared to those of dogs with MPL (307.8 ± 105.3 pg/ml), indicating that serum SP levels increased when the dogs experienced greater pain.

Conclusion: These findings propose the possibility that SP might be a useful biomarker for pain assessment in dogs. The present study may provide fundamental data that can aid in future pain management in dogs.

Citing Articles

The Role of Biomarkers in Acute Pain: A Narrative Review.

Asimakopoulos T, Tsaroucha A, Kouri M, Pasqualucci A, Varrassi G, Leoni M Pain Ther. 2025; .

PMID: 40088258 DOI: 10.1007/s40122-025-00718-6.


Effect of classical music on light-plane anaesthesia and analgesia in dogs subjected to surgical nociceptive stimuli.

Georgiou S, Anagnostou T, Sideri A, Gouletsou P, Athanasiou L, Kazakos G Sci Rep. 2024; 14(1):19511.

PMID: 39174615 PMC: 11341903. DOI: 10.1038/s41598-024-70343-4.

References
1.
Jessell T . Substance P in nociceptive sensory neurons. Ciba Found Symp. 1982; (91):225-48. DOI: 10.1002/9780470720738.ch13. View

2.
Jang M, Park J, Kho H, Chung S, Chung J . Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis. 2010; 17(2):187-93. DOI: 10.1111/j.1601-0825.2010.01717.x. View

3.
OConnor D, Bernstein K . Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med. 1984; 311(12):764-70. DOI: 10.1056/NEJM198409203111204. View

4.
Srithunyarat T, Hagman R, Hoglund O, Stridsberg M, Olsson U, Hanson J . Catestatin, vasostatin, cortisol, and pain assessments in dogs suffering from traumatic bone fractures. BMC Res Notes. 2017; 10(1):129. PMC: 5359833. DOI: 10.1186/s13104-017-2450-y. View

5.
Srithunyarat T, Hoglund O, Hagman R, Olsson U, Stridsberg M, Lagerstedt A . Catestatin, vasostatin, cortisol, temperature, heart rate, respiratory rate, scores of the short form of the Glasgow composite measure pain scale and visual analog scale for stress and pain behavior in dogs before and after ovariohysterectomy. BMC Res Notes. 2016; 9:381. PMC: 4969733. DOI: 10.1186/s13104-016-2193-1. View